The use of biological response modifiers in parasitic infections.
D000276:Adjuvants, Immunologic / Q000494:pharmacology*; D000818:Animals; D001500:BCG Vaccine / Q000276:immunology*; D003602:Cytotoxicity, Immunologic; D006168:Guinea Pigs; D000949:Histocompatibility Antigens Class II / Q000276:immunology; D007371:Interferon-gamma / Q000276:immunology; D008114:Liver Neoplasms, Experimental / Q000276:immunology / Q000628:therapy; D008262:Macrophage Activation; D008264:Macrophages / Q000276:immunology; D051379:Mice; D010272:Parasitic Diseases / Q000276:immunology* / Q000517:prevention & control / Q000628:therapy; D051381:Rats; D012555:Schistosomiasis mansoni / Q000276:immunology
D000276:Adjuvants, Immunologic; D001500:BCG Vaccine; D000949:Histocompatibility Antigens Class II; D007371:Interferon-gamma